is glp-1 real A monthly dose could cut the number of shots patients take each year from 52 to 12. Side effects from the drug — mainly gastrointestinal symptoms — were similar to or Phentermine vs. GLP-1 Injections: What's

That third arm is thought to drive its unusually large weight effect

Most clients begin noticing effects within the first week of treatment

Early research is reassuring

More potent medicines, such as semaglutide, tirzepatide, and liraglutide, may have superior anti-inflammatory effects

The difference between the groups as measured by a test looking at someones tremors and rigidity was small, almost but not quite reaching what is deemed to be a clinically significant difference

Clinical scenarios warranting consideration of GLP-1 therapy include: Type 2 diabetes management : Per ADA 2024 Standards of Care, GLP-1 RAs may be considered as initial therapy in patients with established atherosclerotic cardiovascular disease (ASCVD), high ASCVD risk, chronic kidney disease (CKD), or heart failure, or as add-on therapy when glycemic targets aren't met Established cardiovascular disease : Several GLP-1 receptor agonists have demonstrated cardiovascular risk reduction in patients with type 2 diabetes and established ASCVD Chronic kidney disease : While SGLT2 inhibitors are generally prioritized for CKD with type 2 diabetes when eGFR allows, GLP-1 RAs may provide complementary benefits Obesity with complications : When lifestyle interventions produce insufficient weight loss in patients with obesity-related comorbidities Important safety considerations include: Contraindications : Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2